Skip to main content
Premium Trial:

Request an Annual Quote

Pall s New Center of Excellence in Bangalore Will Have Proteomics Component

 NEW YORK, March 21 (GenomeWeb News) -

Pall has opened a Center of Excellence in Bangalore, India, that will include a process proteomics lab for chromatography and down-stream systems, Pall said today.

 

The center will also offer clients validation services for FDA approval.

 

"The process proteomics facility is a service to our customers," said Holly Haughney, vice president of Pall BioPharmaceuticals Marketing Asia. "In addition, we will have a training facility because while there is a very well-educated technical force [in India], we've found that much of it is theoretical."

 

Haughney recently relocated to the Bangalore office, along with Vinay Joban, general manager of Pall Life Sciences India.

 

Pall's biopharm business in Asia grew by 14 percent over the last fiscal year, the company said in a statement.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.